Federal workers gain fertility treatment coverage under new health benefit mandate

What it does

This bill requires Federal employee health insurance plans to cover assisted reproductive treatments—including fertility preservation, artificial insemination, in vitro fertilization, genetic testing of embryos, and fertility medications. The coverage becomes mandatory one year after enactment, expanding benefits for roughly 9 million federal workers and retirees seeking to build families through fertility services.

Why we flagged it

The bill's sole operative mechanism is to mandate coverage of fertility treatments in the Federal Employee Health Benefits program. It is a straightforward expansion of health benefits for a defined population of federal workers.

What the text implies

• Fertility coverage mandate may increase FEHB plan premiums for all federal employees, including those who do not use fertility services, though the magnitude depends on utilization rates and plan design.
• The definition of 'fertility treatment' includes a catch-all clause ('such other...services as the Director...determines appropriate'), delegating future scope expansion to OPM and HHS without requiring congressional action.
• One-year implementation window may create administrative burden for FEHB carriers to design, price, and integrate fertility benefit networks.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Federal employees and their families gain access to fertility treatments that were previously not mandated under their health plans, reducing out-of-pocket costs for reproductive care. The bill expands health coverage for a defined population without restricting anyone's existing rights or protections.

Who stands to gain

• fertility clinics and reproductive medicine providers
• pharmaceutical companies supplying fertility medications
• genetic testing laboratories
• FEHB health insurance carriers (through increased premium revenue)

Named in the bill

Federal Employee Health Benefits (FEHB) program, Office of Personnel Management (OPM), Department of Health and Human Services (HHS), 5 U.S.C. § 8904, Federal employees and retirees

Where it stands

3 cosponsors: 3 Democrats.

• Feb 27, 2025 — Introduced · Congress.gov: “Introduced in House”
• Feb 27, 2025 — Referred to House Committee on Oversight and Government Reform · Congress.gov: “Referred to the House Committee on Oversight and Government Reform”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

9 lobbying clients named this bill on 17 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $3,599,812 in lobbying spend. A filing names 32 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 89% of bills with at least one filing.

Gerald Connolly, the sponsor, reported $160,000 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,715,904 on 2 filings
• National Treasury Employees Union — $690,000 on 2 filings
• Ferring Pharmaceuticals, Inc. — $540,000 on 2 filings
• Human Rights Campaign — $439,908 on 2 filings
• Hadassah, the Women's Zionist Organization of America, Inc. — $120,000 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.